# Ryaltris

NDC: 59467-700
Generic name: olopatadine hydrochloride and mometasone furoate
Labeler / Manufacturer: HIKMA SPECIALTY USA INC.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: SPRAY, METERED
Routes: NASAL
Marketing started: 20220815

FDA application: NDA211746

## Active ingredients

- MOMETASONE FUROATE MONOHYDRATE: 25 ug/1
- OLOPATADINE HYDROCHLORIDE: 665 ug/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"59467-700"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=59467-700
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=382eac74-a7ce-4f42-ac0a-b253308f335f